Per Sandberg (#1970)
- $ 2 B
- Pharmaceuticals
- Sweden
- M
- 64 Years
Rest in Peace Ask Jeeves, every search comes to an end
County commissioners call on lawmakers to up funding for 911 dispatch systems
Spirit Airlines Is Going Out Of Business; Effective IMMEDIATELY
Pokémon Scalpers Selling Limited-Edition Pop-Tarts For Ridiculous Prices
Bennett says Netanyahu gov't 'boycotting' West Bank settlements amid Carrefour subsidy deal
Golf gear on sale now: Up to 65% off adidas, 45% off Puma, 15% off Mizuno, more
Families across the US can't find childcare — this map shows where it's worst
Median sales surge 61% in a Queens neighborhood that’s now the fifth priciest in NYC
Greg Brockman says his stake in OpenAI is worth nearly $30 billion
TeraWulf Announces Participation in Upcoming Investor and Industry Conferences
About Me
Per Sandberg is a major shareholder in pharmaceutical company Camurus, which develops treatment for opiod dependency. He inherited the stakes from his father, entrepreneur Gunnar Sandberg. He is also the sole owner of Aimpoint ? the world leader in red dot sights for hunting, sport shooting, and military use. Sandberg Development is his family-owned investment company, focusing on water technology, quality of life, and security. Per Sandberg has three siblings, all of whom have been bought out of Sandberg Development. He now owns the company together with his three sons.
Achievements
Career Highlights
A snapshot of the defining milestones, leadership decisions, and breakthroughs that shaped Per Sandberg’s rise and global influence.
Wealth Growth
Net Worth Growth Over Time
Tracking Per Sandberg’s net worth journey over the years, highlighting key growth phases and financial milestones.
Current Net Worth: $2.1B
(May 4, 2026)
© Iconic Billionaires